Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2006-09-14

Clinical Trial Update: Effects of Oral Salmon Calcitonin in Human Osteoarthritis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating oral salmon calcitonin for osteoarthritis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Salmon Calcitonin (salmon calcitonin)

Snippet

Sponsor: Université Catholique de Louvain | Conditions: Osteoarthritis | Phase 2 | Status: TERMINATED